Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
7/6/23 18:45 | 7/3/23 | ISEE | Health | Drug | Pharmaceutical Preparations | Westby Keith | NJ | O | SVP,COO | S.d | -789 | 39.45 | 0 | -20 | -34 | 40 | D | ||||||||||||||
6/6/23 16:53 | 6/2/23 | ISEE | Health | Drug | Pharmaceutical Preparations | Westby Keith | NJ | O | SVP,COO | S.d | -757 | 37.87 | 0 | -20 | -34 | 40 | D | ||||||||||||||
5/3/23 17:31 | 5/1/23 | ISEE | Health | Drug | Pharmaceutical Preparations | Westby Keith | NJ | O | SVP,COO | S.dm | -1,499 | 37.47 | 0 | -40 | -50 | 40 | D | ||||||||||||||
5/3/23 17:31 | 5/1/23 | ISEE | Health | Drug | Pharmaceutical Preparations | Carroll David Francis | NJ | O | SVP,CFO | S.d | -2,352 | 37.04 | 0 | -64 | -48 | 68 | D | ||||||||||||||
4/25/23 19:27 | 4/21/23 | ISEE | Health | Drug | Pharmaceutical Preparations | Carroll David Francis | NJ | O | SVP,CFO | S.dm | -1,510 | 30.20 | 0 | -50 | -42 | 68 | D | ||||||||||||||
4/25/23 19:25 | 4/21/23 | ISEE | Health | Drug | Pharmaceutical Preparations | Westby Keith | NJ | O | SVP,COO | S.dm | -601 | 30.07 | 0 | -20 | -34 | 40 | D | ||||||||||||||
4/5/23 18:48 | 4/3/23 | ISEE | Health | Drug | Pharmaceutical Preparations | Westby Keith | NJ | O | SVP,COO | S.d | -1,068 | 26.70 | 0 | -40 | -50 | 40 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |